Company ProfilePremium

Ekopak NV

Company Profile Analysis

Ticker: EKOP.BR

ESOMAR 23 Corporate BadgeISO Certifications Badge
Ekopak NV - Company showcase

Year Founded & Workforce

1997

265 Employees

Ekopak NV logo

Ekopak NV Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Ekopak NV Overview

Ekopak is a small-cap Belgian industrial water specialist that designs, builds, finances and operates decentralised process-water and wastewater treatment installations for water-intensive industrial customers in food, chemicals, pharma, cosmetics, steel and energy. Its differentiating model is Water-as-a-Service (WaaS): containerised, modular units that convert alternative sources (rainwater, surface water, treated effluent) into process water under long-term "pay-by-the-drop" contracts, in which Ekopak retains ownership and operating responsibility. The 2023 acquisition of Global Water & Energy (GWE) added anaerobic and industrial wastewater engineering and a footprint in Southeast Asia and the Americas, doubling revenue and pushing roughly half of sales outside Europe. Group revenue reached EUR 51.1m in FY2025, but the company remains loss-making, carries net financial debt of roughly EUR 74–80m, operates under an auditor-flagged material going-concern uncertainty, and has been through a turbulent 18 months of leadership turnover, a regulatory investigation and the near-collapse of its flagship Waterkracht project.


Company's own description

In its 2026 press materials Ekopak describes itself as a Belgian company specialised in industrial water treatment and wastewater treatment, whose solutions allow industrial clients to reduce water consumption sustainably, reliably and profitably, purify their wastewater, decouple from the public water network and start circular water use. It emphasises modular water purification units that transform off-grid sources (rain-, surface- and/or wastewater) into cleaner water usable and reusable in client processes. The IFRS notes describe Ekopak as a responsible and sustainable supplier of mission-critical industrial process water to customers worldwide. [Source: 1H2026 press release; 1H2026 IFRS interim statements, note 1]

The Euronext issuer profile adds that solutions can be offered either as standalone design-build (with optional operate and/or maintain services) or as a WaaS package delivering an end-to-end solution under a long-term contract with per-volume pricing. [Source: Euronext issuer page]

Business model and revenue model

SegmentRevenue logicRecognitionFY2025 revenue (EUR Mn)Share
Project BusinessOne-off design & build of process-water and wastewater treatment plants; ownership transfers to clientOver time, milestone-based (engineering & procurement → equipment/factory construction → siteworks → start-up & commissioning)36.671.6%
Recurring BusinessServices, consumables, rentals, O&M, and WaaS (guaranteed minimum water volume of contractual quality over contract life)Consumables and single services point-in-time; services and WaaS over time14.528.4%

Since January 2025 (internal reporting) and September 2025 (organisational implementation), Ekopak reports two segments:

[Source: FY2025 audited segment note; 1H2026 note 5]

Revenue by product type (FY2025, EUR thousands): consumables 1,956; services 8,523; one-off projects 36,178; WaaS 4,460; total 51,117. (Note: the product-type "one-offs" line of 36,178 differs slightly from the Project Business segment revenue of 36,625 — a EUR 0.45m classification difference between the two disclosures; not reconciled by the company.) [Source: FY2025 results press release]

Mix characterisation: roughly 71% project/product (lumpy, milestone-driven, working-capital intensive), 17% services, 4% consumables and 9% WaaS/subscription-like in FY2025. In 1H2026 the recurring share rose to 40% (WaaS 4.4m, services 4.0m, consumables 1.1m of 23.5m), driven by the NWB Tilburg acquisition. There is no licensing revenue.

WaaS / DBFMO accounting. Ekopak judges that its DBFMO (design-build-finance-maintain-operate) WaaS contracts do not contain a lease under IFRS 16, because it retains substantive substitution rights and the customer cannot direct the asset's use; the contracts are therefore accounted for under IFRS 15. WaaS contracts contain a EUR 1 purchase option at the end of the non-cancellable term, but management assumes renewal on the same terms when setting asset useful lives. [Source: 1H2026 note 4.2 and 4.8]

Financing model shift (2026). Historically, WaaS assets were financed on balance sheet during construction and then monetised via sale-and-leaseback with financial institutions (carrying value of such assets EUR 13.5m at 30 June 2026). In January 2026 Ekopak signed a long-term partnership with an unnamed infrastructure fund to finance WaaS and Circeaulair installations through project companies that will not be consolidated, with Ekopak acting as EPC partner; a similar structure is being set up in Asia with regional investors. Management acknowledged this will lower consolidated EBITDA margins but argued it improves free cash flow and return on equity. As of 1H2026 no WaaS installations had yet been sold into the off-balance structure. [Source: FY2025 press release; 1H2026 press release; CB Insights news excerpt, 27 January 2026]

Value-chain position

Ekopak sits at the engineering/integration and asset-ownership layer of the industrial water value chain: it designs systems, procures membranes, pumps and components, assembles process-water installations in its own factory (wastewater plants are typically built on site, with siteworks often subcontracted but recognised gross as principal), commissions and then operates/maintains them. It does not manufacture core membrane technology. Its WaaS and Circeaulair models push it further downstream into utility-like water supply. [Source: 1H2026 note 4.3]

Customers and end-markets

The company states that it works only with customers in the chemical, pharmaceutical and food industries with outstanding credit ratings, and that historical credit losses have been very limited. Named customers/projects in disclosures include TotalEnergies (Grandpuits, France — first major French WaaS), ArcelorMittal (Belgium WaaS), Agristo (India project; also an NWB Tilburg user), Nexus W2V (waste-to-value, USA), a large US-based brewery (contract announced 1H2025), and the four NWB Tilburg anchor users (Agristo, Coca-Cola, Fujifilm, IFF). One customer group accounted for EUR 2.3m or 10% of 1H2026 revenue (13% in 1H2025) under contracts with a total value of EUR 47.2m. [Source: 1H2026 note 7.1; 1H2025 note 6.1; FY2025 press release; LinkedIn post re TotalEnergies]

Independent characterisation

Ekopak is best understood as a sub-scale, project-heavy industrial water engineering contractor attempting to transition into a capital-light, recurring-revenue water utility for industry. The strategic logic — water scarcity, rising tariffs and discharge rules pushing industrials toward reuse — is sound, and the GWE deal gave genuine international reach and wastewater competence. Execution, however, has been poor: revenue is volatile half-to-half, adjusted EBITDA has been negative for two consecutive full years, the balance sheet has been levered to fund WaaS assets and a large new headquarters, and the flagship Waterkracht project has become a credibility problem rather than an asset. The company is effectively dependent on continued support from its majority shareholder Alychlo.

Strategy

Stated strategy themes (2025 Integrated Annual Report and results releases)

Paraphrased themes: (i) two business pillars — one-off projects and recurring WaaS — with WaaS as the long-term value driver; (ii) a strategic shift to off-balance-sheet WaaS financing to enable scalable, capital-efficient growth while preserving shareholder value; (iii) being a "total solution" partner combining process water and wastewater after GWE; (iv) international expansion (Asia, Americas, India); (v) circular water at district scale (Circeaulair, Waterkracht, NextGen District); (vi) cost discipline and organisational streamlining.

Initiatives in the last 24 months

InitiativeDateDescription / targetStatus
Capital increaseMay-2025EUR 15m at EUR 5.60Completed
Leadership renewalMay–Sep 2025New chair, CFO, CEO; Cockpit modelPartially reversed: CEO left Jul-2026, Cockpit abolished Sep-2026
Business-unit reorganisationSep-2025Project vs Recurring BUs cutting across legal entitiesImplemented
Cost rationalisation programmeSep-2025"Substantial run-rate savings" (no number disclosed)FTE down from 290 to 265 by Jun-2026
Off-balance WaaS partnershipJan-2026Infrastructure fund finances WaaS/Circeaulair via project companies; fund also sources projectsSigned; no transfers at 30-Jun-2026
Asian off-balance structure2,026Similar vehicle with regional investorsIn set-up
NWB Tilburg acquisitionJan-2026First wastewater WaaSClosed
India subsidiaryJan-2026Local presenceIncorporated
Additional cost reductionsSep-2026Right-size organisation (no target disclosed)Announced
Capital searchSep-2026New equity with financial adviserOngoing
Asset monetisationSep-2026Portfolio of water installations that can be monetisedOngoing

Medium-term targets

2028 target (reiterated 2 March 2026): revenue of at least EUR 140m and EBITDA of EUR 35–42m. [FY2025 PR]

2026 guidance: "significant" revenue growth vs 2025 with further improvement in operating EBITDA; WaaS revenue expected to double vs 2024. Reconfirmed 1 September 2026. [1H2026 PR]

Status of 2028 targets: KBC Securities noted that the 1H2026 release no longer repeated the 2028 ambitions. Analyst view: given FY2025 revenue of EUR 51m and negative EBITDA, the 2028 targets should be treated as effectively suspended.

Products & Services

Ekopak does not publish a priced product catalogue; pricing models are disclosed only at the business-model level. Technical specifications for individual units are not publicly disclosed in the sources reviewed.

Project Business offerings

OfferingDescriptionTarget customerLaunch / statusPricing model
Containerised process-water installationsModular, factory-built units that treat rain-, surface- or wastewater into process water (cooling, boiler feed, process use); typically housed in transportable containers connected to client tanksWater-intensive plants in food, chemicals, pharma, cosmetics, paperCore legacy product; ongoingOne-off design & build contract, milestone-billed
Industrial wastewater treatment plants (GWE heritage)Design & build of wastewater plants, including anaerobic treatment (GWE founder pioneered modern anaerobic treatment) and waste-to-value/energy schemesFood & beverage, agri-processing, breweries, industrial parks globallyAcquired Sep-2023One-off EPC contract, milestone-billed
Turnkey "total solution" projectsCombined process-water + wastewater scope; recent named projects: Agristo (India), Nexus W2V (USA), large US breweryMultinationals' international sites2025–2026 backlogEPC
EPC for off-balance WaaS/Circeaulair assetsFrom 2026, Ekopak acts as EPC partner building installations owned by infrastructure-fund project companiesFund-owned asset companiesPartnership signed Jan-2026; no transfers yet at 30-Jun-2026EPC margin

Recurring Business offerings

OfferingDescriptionTarget customerLaunch / statusPricing model
Water-as-a-Service (WaaS) / DBFMOEkopak designs, builds, finances, maintains and operates the installation on the client site and contractually supplies a guaranteed minimum volume of water of contractual qualityIndustrial sites wanting off-balance-sheet water supplyFlagship model; named WaaS sites include TotalEnergies Grandpuits (FR) and ArcelorMittal (BE); three new WaaS projects operational in 1H2025Long-term "pay-by-the-drop" volume pricing; EUR 1 purchase option at end of term
WaaS for wastewater — NWB TilburgCentral private industrial wastewater plant on the Fujifilm site in Tilburg treating effluent of Agristo, Coca-Cola, Fujifilm and IFF; first wastewater application within WaaSIndustrial clustersAcquired 1-Jan-2026; contributed EUR 2.17m revenue and EUR 0.52m EBITDA in 1H2026Service fees from four users
Circeaulair (circular water)Converting effluent from Aquafin wastewater plants into industrial process water delivered by new pipeline networks to companies or business parks; executed through JV Circeaulair I (51%)Business parks, industrial clusters in FlandersSupplier agreement Jun-2023; projects delayed vs subsidy timelineLong-term supply contracts within JV; Ekopak earns EPC and maintenance fees
Waterkracht (project initiative)Repurposing c. 20 billion litres/year of Aquafin-treated Antwerp household wastewater into cooling water for Port of Antwerp industry; Ekopak to build and run the membrane plant; >EUR 100m direct and indirect investmentPort of Antwerp industrialsLaunched 2022; EPICo II withdrew Feb-2026; excluded from FY2025 accounts; current status not publicly disclosedWould have been long-term WaaS
NextGen District concessionDecentralised water supply concession in Antwerp's NextGen District, separate from WaterkrachtDistrict occupantsDisclosed Sep-2024; status n/d—
ServicesLegionella prevention, disinfection, boiler-water treatment, corrosion control, maintenance and operation of client-owned installations; iSERV heritageInstalled base and third-party plantsOngoing; FY2025 services revenue EUR 8.5mService contracts / call-outs
ConsumablesTreatment chemicals and replacement partsInstalled baseOngoing; FY2025 EUR 2.0mUnit sales
Rentals and pilot installationsRental containers and pilot units for trials and temporary supplyClients testing reuse; emergenciesOngoing; some financed via sale-and-leasebackRental fees
Remote monitoring platformCloud platform used to monitor service activities and installations (capitalised software)Internal/installed baseIn useBundled
WaaS AsiaSingapore JV (51%) to reduce water footprint of industrial customers across Asia; cooperation with Vyncke referenced in the 2025 annual reportAsian industrial sitesEstablished 2024; first contract signed by 1H2026, no revenue yetWaaS

Financial Narrative

Data basis. FY2024–FY2025 from audited consolidated statements in the FY2025 results release (FY2024 as restated).

Income statement

Revenue CAGR FY2021–FY2025: c. 46% p.a. (EUR 11.25m → EUR 51.1m), heavily acquisition-driven (iSERV 2021, H2O Production 2022, GWE September 2023). Organic growth is not disclosed.

Gross profit. Ekopak presents costs by nature and does not report gross profit. A proxy (revenue less purchases of materials) is shown below for the two audited years only; TipRanks' FY2021–FY2023 "gross profit" uses a different definition and is not comparable.

Adjusted EBITDA (company definition, before one-off/non-operating items):

FY2025 EBITDA adjustments (net -EUR 0.886m) include the EUR 1.83m gain on the Tielt HQ sale (partly offset by EUR 0.25m costs), a EUR 0.25m legal settlement, EUR 0.41m start-up costs of foreign business, EUR 0.085m CEO/CFO recruitment and EUR 0.037m severance. The removal of Waterkracht from the accounts reduced FY2025 EBITDA by EUR 1.646m in total (EUR 0.367m at adjusted EBITDA level, EUR 1.28m at EBITDA level). [Source: FY2025 PR; 1H2025/1H2026 note 5]

H1-2026 snapshot (unaudited): revenue EUR 23.5m (+9%); adjusted EBITDA -EUR 1.2m (-5% margin); EBITDA +EUR 3.4m (including EUR 4.96m NWB badwill); operating loss before badwill -EUR 6.9m; net loss -EUR 1.8m after EUR 2.0m deferred tax credit; EPS -EUR 0.10. [Source: 1H2026 interim statements]

Commentary on income-statement trends. The inflection point was 2024: revenue still grew strongly (on the restated basis +32%) but the cost base expanded faster — personnel costs rose from EUR 17.0m (2024) to EUR 20.8m (2025) and depreciation from EUR 8.4m to EUR 9.6m as the Deinze campus and WaaS assets came on stream. Financial costs rose from EUR 2.9m to EUR 4.0m as debt grew. The H2-2025 recovery (revenue EUR 29.4m, +95% YoY; adjusted EBITDA +EUR 0.36m) proved that the business can break even at a semi-annual run-rate near EUR 30m, but the reversion to EUR 23.5m in 1H2026 shows the volatility of milestone-based project recognition. Reported net losses are cushioned by deferred tax income (EUR 3.9m in FY2025), which depends on management's judgement that carried-forward losses (EUR 52.9m at June 2026) will be recovered.

Balance sheet

FY2023 year-end reference points: total equity EUR 53.517m; borrowings and leases EUR 42.957m; cash EUR 12.679m (from opening balances in the FY2024 statements). Full FY2021–FY2023 balance sheets are not publicly disclosed in the sources reviewed.

30 June 2026 (unaudited): total assets EUR 162.9m; cash EUR 5.5m; borrowings excl. leases EUR 79.1m (ST 29.3m, LT 49.7m); leases EUR 6.4m; net financial debt excl. leases EUR 73.5m (EUR 79.9m incl. leases — consistent with KBC Securities' "c. EUR 80m"); equity EUR 41.1m; solvency ratio 25%. Borrowing mix: investment credits EUR 41.7m, straight loans EUR 21.1m, client-project investment loans EUR 11.7m, subordinated shareholder loan EUR 4.4m (debt component of the April 2026 convertible), leases EUR 6.4m. [Source: 1H2026 note 16]

Data-quality flag: the non-GAAP note in the 1H2026 report labels 31 December 2024 balances (borrowings EUR 71.240m, cash EUR 9.706m, net debt EUR 61.534m, equity EUR 41.205m) as "31 December 2025". The correctly computed 31 December 2025 net financial debt excl. leases is EUR 68.7m.

Cash flow

H1-2026: OCF +EUR 0.76m (first positive half-year OCF in the period reviewed, helped by EUR 1.7m higher contract liabilities and EUR 2.1m lower receivables); capex EUR 1.4m; acquisition of NWB EUR 2.15m; net borrowings +EUR 3.4m; cash down EUR 2.0m to EUR 5.5m. [Source: 1H2026 cash flow statement]

Ratios

Notes: ROE/ROA on average balances (FY2023 equity 53.5m used for FY2024 average; FY2023 total assets not disclosed, so FY2024 ROA uses year-end assets). Net debt/EBITDA and interest coverage are not meaningful with negative EBITDA/EBIT and are shown for completeness only. Cash conversion cycle is not computable from disclosed data (cost of sales not reported); DSO on trade receivables was c. 101 days in FY2025 (14.2m / 51.1m x 365), unusually high against stated 30-day payment terms, partly reflecting year-end project billing.

Overall financial commentary. Ekopak's financial profile is that of a growth-stage company that has run ahead of its funding: it has consumed roughly EUR 51m of free cash flow in two years against EUR 15m of new equity, financing the balance through bank debt that the banks have now partly placed under a principal moratorium. Book equity has been held flat only by the 2025 capital increase. Goodwill and intangibles (EUR 47.5m) exceed total equity (EUR 42.2m), meaning tangible equity is negative. The auditor's going-concern emphasis paragraph, the 1H2026 disclosure that continuity depends on successful monetisation of assets, and the need for successive shareholder loans make liquidity the single most important analytical variable.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Segment revenue (EUR Mn)

Segment revenue (EUR Mn)FY2024FY2025

Project Business

35.45436.625

Recurring Business

12.18314.492

Total revenue

47.63751.117

Segment growth and mix (%)

Segment growth and mix (%)FY2024FY2025

Project Business YoY growth

03.3

Recurring Business YoY growth

019.0

Project Business share of revenue

74.471.6

Recurring Business share of revenue

25.628.4

Results by Segment

Segment metric (EUR Mn)FY2024FY2025

Project Business adjusted EBITDA

-3.986-2.943

Recurring Business adjusted EBITDA

0.036-0.477

Project Business EBITDA

-4.670-4.303

Recurring Business EBITDA

0.036-0.003

Project Business operating result

-9.557-9.913

Recurring Business operating result

-3.503-4.029

Project Business pre-tax result

-10.789-12.361

Recurring Business pre-tax result

-4.715-5.021

Segment margins (%)

Segment margins (%)FY2024FY2025

Project Business adjusted EBITDA margin

-11.2-8.0

Recurring Business adjusted EBITDA margin

0.3-3.3

Project Business pre-tax margin

-30.4-33.8

Recurring Business pre-tax margin

-38.7-34.6

Results by Segment (Half-Yearly)

Segment metric (EUR Mn)H1-2024H1-2025H1-2026

Project Business revenue

26.94115.49814.073

Recurring Business revenue

5.6406.1899.475

Total revenue

32.58121.68723.549

Project Business adjusted EBITDA

2.192-2.682-2.565

Recurring Business adjusted EBITDA

-0.184-1.0991.355

Group adjusted EBITDA

2.008-3.781-1.210

Project Business EBITDA

1.955-2.321-2.832

Recurring Business EBITDA

-0.184-0.6616.232

Group EBITDA

1.771-2.9823.400

Project Business pre-tax result

-0.446-5.773-6.908

Recurring Business pre-tax result

-2.043-3.1723.219

Income statement (EUR Mn)

Income statement (EUR Mn)FY2021FY2022FY2023FY2024FY2025

Revenue

11.2517.7136.0347.63751.117

EBITDA (reported)

0.371-0.4093.48-4.634-4.306

Operating income (EBIT)

-0.611-2.29-3.40-13.060-13.942

Pre-tax income

-0.748-2.52-4.00-15.504-17.383

Net income

-0.70-1.99-3.08-12.232-13.826

EPS basic (EUR)

-0.05-0.13-0.21-0.83-0.79

EPS diluted (EUR)

-0.05-0.13-0.21-0.83-0.79

Dividend per share (EUR)

00000

Margins (%)

Margins (%)FY2021FY2022FY2023FY2024FY2025

EBITDA margin

3.3-2.39.7-9.7-8.4

Operating margin

-5.4-12.9-9.4-27.4-27.3

Net margin

-6.2-11.2-8.5-25.7-27.0

Growth (%)

Growth (%)FY2022FY2023FY2024FY2025

Revenue YoY growth

57.4103.432.27.3

Gross margin proxy (EUR Mn)

Gross margin proxy (EUR Mn)FY2024FY2025

Revenue less purchases of materials

18.53622.074

Proxy gross margin (%)

38.943.2

Adjusted EBITDA (EUR Mn)

Adjusted EBITDA (EUR Mn)FY2024FY2025

Adjusted EBITDA

-3.950-3.420

Adjusted EBITDA margin (%)

-8.3-6.7

Balance Sheet

Balance sheet (EUR Mn)FY2024FY2025

Total assets

155.982158.575

Cash and cash equivalents

9.7067.563

Short-term borrowings

22.69127.008

Long-term borrowings

48.54949.292

Lease liabilities (short + long)

6.2586.670

Total financial debt incl. leases

77.49882.970

Net financial debt excl. leases

61.53468.737

Net debt incl. leases

67.79275.407

Total equity

41.20542.220

Goodwill

19.34919.349

Intangible assets

30.83028.110

Goodwill and intangibles

50.17947.459

Current assets

42.10739.247

Current liabilities

52.79354.580

Working capital (current assets less current liabilities)

-10.686-15.333

Deferred tax assets

6.91310.895

Cash flow (EUR Mn)

Cash flow (EUR Mn)FY2024FY2025

Operating cash flow

-3.940-8.896

Capex (PP&E + intangibles)

27.16410.934

Free cash flow (OCF less capex)

-31.104-19.830

Proceeds from disposals of PP&E

0.1333.692

Net new borrowings (proceeds less repayments, excl. leases)

31.7645.060

Equity raised (gross)

015.000

Interest paid

2.6813.066

Dividends paid

00

Share buybacks

00

Returns & Leverage Ratios (%) and Financial Ratios (x)

RatiosFY2024FY2025

ROE (%)

-25.7-33.1

ROA (%)

-8.6-8.8

ROIC (%, NOPAT proxy = EBIT x 0.75 / avg equity + net debt)

-9.5-9.1

Current ratio (x)

0.800.72

Debt/equity (x, incl. leases)

1.881.97

Net debt/EBITDA (x)

-14.6-17.5

Interest coverage EBIT/financial costs (x)

-4.4-3.5

Asset turnover (x)

0.340.33

Solvency ratio equity/total assets (%)

26.426.6

Revenue by region (EUR Mn)

Revenue by region (EUR Mn)H1-2024H1-2025H1-2026

Belgium

8.7515.7946.401

Rest of Europe

9.7985.7976.380

APAC

0.6441.8283.237

Africa

1.0500.7780.549

Americas

12.3387.4906.982

Total

32.58121.68723.549

Regional YoY growth (%)

Regional YoY growth (%)H1-2025H1-2026

Belgium

-33.810.5

Rest of Europe

-40.810.1

APAC

183.977.1

Africa

-25.9-29.4

Americas

-39.3-6.8

Total

-33.48.6

Regional share of revenue (%)

Regional share of revenue (%)H1-2024H1-2025H1-2026

Belgium

26.926.727.2

Rest of Europe

30.126.727.1

APAC

2.08.413.7

Africa

3.23.62.3

Americas

37.934.529.6

Calendar-year share price return (%)

Calendar-year share price return (%)FY2022FY2023FY2024FY2025

EKOP total price return

-3.6710.69-26.37-62.41

Period return (%)

Value

———

2026 year-to-date (to 16-Oct-2026)

-54.7———

1-year (to 2-Oct-2026)

-45.1———

Since 31-Dec-2023 (proxy for ~3 years; derived from calendar returns)

-87———

Since IPO at EUR 14.00 (31-Mar-2021) to EUR 2.40

-83———

52-week range (as of early Oct-2026)

EUR 2.755 – 6.60

———

Valuation Multiples

MultipleEkopakSource

Market capitalisation

EUR 42.0m

MarketScreener / derived

Enterprise value

c. EUR 115m

MarketScreener

EV/Sales 2026e

1.68x

MarketScreener consensus

EV/Sales 2027e

1.53x

MarketScreener

P/E 2026e

-16x (n/m)

MarketScreener

P/B (on 30-Jun-2026 equity EUR 41.1m)

1.02x

derived

EV/EBITDA

n/m (negative adjusted EBITDA)

—

Dividend yield

0%—

Analyst Ratings & Targets

BrokerDateRating / targetNotes

Berenberg

17-Oct-2024

Buy, EUR 28.00

—

Berenberg

10-Jan-2025

Buy, EUR 22.00

Current status n/d

Kepler Cheuvreux

Sep-2025

Liquidity warning

Rating n/d

KBC Securities

02-Mar-2026

Hold EUR 5.50 placed under review

—

KBC Securities

03-Aug-2026

Hold, EUR 4.60

—

KBC Securities

01-Sep-2026

Rating and target withdrawn

Cited lack of portfolio update, infra-fund progress and liquidity

Analyst Conclusions

Management guidance

  • FY2026: significant revenue growth vs FY2025 (EUR 51.1m), with further improvement in operating EBITDA; much stronger H2 expected as backlog moves into execution. WaaS revenue to double vs 2024 (i.e., to c. EUR 7–8m based on FY2024 WaaS levels; FY2024 full-year WaaS figure itself not disclosed in sources reviewed).

  • Medium term: 2028 targets (≥EUR 140m revenue, EUR 35–42m EBITDA) were reiterated in March 2026 but omitted in September 2026.

  • Consensus (MarketScreener-implied): EV/Sales of 1.68x 2026e on EV of EUR 115m implies 2026e revenue of c. EUR 68m and c. EUR 75m for 2027e — consensus is based on very thin coverage following KBC's withdrawal.

Bull case

  1. H2 backlog conversion: with EUR 49m of project backlog and higher contract liabilities (EUR 16.3m at June 2026, up EUR 2.6m), a strong H2-2026 could repeat the H2-2025 pattern and deliver a positive full-year adjusted EBITDA.

  2. Capital-light pivot works: first transfers of WaaS assets to the infrastructure-fund vehicle would crystallise EPC margins, release cash and validate the model, while the EUR 23m DBFMO asset base offers monetisation optionality.

  3. Optionality at a distressed valuation: at c. 1.0x book and c. 0.8x FY2025 sales on market cap, any Waterkracht revival, Asian WaaS traction or strategic interest from a larger water group would be pure upside, with a committed billionaire-backed majority shareholder providing downside support.

Bear case

  1. Highly dilutive recapitalisation: cash of EUR 5.5m, a bank moratorium and repeated shareholder loans point to an equity raise priced near or below EUR 2.40, materially diluting minorities.

  2. Structural unprofitability: Project Business adjusted EBITDA has been negative in five of six reported half-years since H1-2024's peak; the cost base appears too large for a EUR 45–55m revenue business.

  3. Governance and credibility deficit: the Waterkracht episode, the unresolved FSMA investigation, revenue reversals and three CEO regimes in 13 months may deter customers from signing 10–15 year WaaS contracts and investors from funding them.

Key catalysts and monitorables (next 12 months)

CatalystTimingWhat to watch
Capital raise / strategic investorQ4-2026 – H1-2027Price, size, Alychlo participation, minority dilution
Permanent CEO appointmentBy end-2026Profile (turnaround vs growth)
First off-balance WaaS asset transfer2026–2027Cash proceeds, EPC margin recognition
Waterkracht outcomePost Aug-2026New partner or formal termination
FSMA investigation outcomeUnknownSanction, settlement or closure
FY2026 results1-Mar-2027Delivery of "significant growth", adjusted EBITDA sign, auditor opinion wording
NWB purchase-price allocation finalisationBy Jan-2027Badwill confirmation or reduction
Bank moratorium termsOngoingCovenant resets, maturity extension
Cost-reduction quantificationH2-2026Run-rate savings vs EUR 20m+ personnel cost

Concluding analyst verdict

Ekopak sits at an uncomfortable intersection of an attractive long-term theme and a fragile near-term balance sheet. The industrial water-reuse opportunity is real: water stress, tariffs and discharge rules are pushing European and Asian industrials toward decentralised, circular supply, and Ekopak's containerised units, WaaS contracting experience and GWE's wastewater pedigree give it legitimate credentials. The Recurring Business, now including NWB Tilburg, finally showed positive adjusted EBITDA in 1H2026, and the EUR 49m backlog provides genuine visibility for the second half.

But the investment case is currently dominated by financing rather than operations. Over FY2024–FY2025 the company burned roughly EUR 51m of free cash flow, its auditor has flagged a material going-concern uncertainty, cash stood at EUR 5.5m in June, and its four banks have agreed a principal moratorium while the majority shareholder lends successive subordinated tranches. Tangible equity is negative, the 2028 targets have quietly disappeared from the narrative, the flagship Waterkracht project has lost a key partner, an FSMA investigation into past disclosures remains open, and the company is on its third leadership configuration in just over a year. The off-balance infrastructure-fund partnership is the right strategic answer, but nine months after signing, no asset had been transferred.

At EUR 2.40 the market is pricing a high probability of a deeply dilutive recapitalisation. For minority investors, the risk/reward is asymmetric only if one has conviction that Alychlo will backstop a raise at a reasonable price and that the interim CEO can right-size the cost base quickly. Until there is evidence of (i) a completed equity solution, (ii) first off-balance WaaS transfers and (iii) a positive full-year adjusted EBITDA, the stock should be treated as a special-situation, high-risk turnaround rather than a growth investment in water. Stance: Speculative / Avoid for non-specialist mandates; monitor recapitalisation terms as the decisive catalyst.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Executive Leadership Team

NameRoleSinceBackground / notes

Wim Messiaen (via CAMAT BV)

CEO ad interim

3-Aug-2026 (mandate to end-2026)

Prior roles, education and age not disclosed in sources reviewed

Geert Bossuyt (via BOSVAN BV)

CFO

Jun-2025

Co-lender in April 2026 convertible loan; prior roles n/d

Pieter Loose (via Chasqui BV)

Non-executive director (formerly founder-CEO, then Chief Strategy & Growth Officer)

Founder; CEO until Sep-2025; CSGO Sep-2025–Sep-2026; non-executive from Sep-2026

Born 1983 per aggregator; Pilovan BV (25.5% holder) associated with founder; co-lender in April 2026 convertible

Management team

Reporting to CEO (replacing "Cockpit")

Sep-2026

Composition not publicly disclosed

Board of Directors

NameRoleNotes

Jos De Vuyst (via DEVUMA BV)

Chairman

Since May 2025

Pieter Loose (via Chasqui BV)

Non-executive director

Since Sep-2026 (previously executive)

Directors' Remuneration

Remuneration (EUR K)H1-2024H1-2025H1-2026

Key management short-term benefits

1,0297331,066

Key management post-employment benefits

141430

Key management total

1,0437471,096

Board fees (H1)

04343

Major Shareholders

HolderStake 30-Jun-2026 (%)Notes

Alychlo NV (Marc Coucke)

57.6

Majority since May 2025 capital raise; also lender (Apr-2026 convertible; up to EUR 5.639m Sep-2026 loan)

Pilovan BV

25.5

Founder-related vehicle; sold 1,084,637 shares to Alychlo in May 2025

Free float

16.9—

Competitive Landscape

Key Competitors

CompetitorOverlap with Ekopak—Relative positioning

Veolia (Water Technologies)

Industrial process water, reuse, outsourced water services, mobile water

Group revenue c. EUR 45bn (FY2024)

Global leader; full-service BOO/BOT capability; far larger balance sheet

Xylem (incl. Evoqua)

Industrial water treatment, outsourced water services (Evoqua "Water One")

c. USD 8.6bn (FY2024)

Strong US service-based outsourcing; direct WaaS-like competitor in Americas

Ecolab (Nalco Water)

Industrial water chemistry, services, consumables

c. USD 15.7bn (FY2024)

Dominant in treatment chemicals/services overlapping Ekopak's services/consumables

Kurita Water Industries

Industrial water, chemicals, "water as a service" contracts

c. JPY 390bn (FY2024)

Pioneer of outsourced industrial water supply, strong in APAC

SUEZ (post-2022 SUEZ)

Water services, industrial water

—

Large utility/industrial services player in Europe

Paques (Netherlands)

Anaerobic industrial wastewater treatment

Private; n/d

Direct competitor to GWE heritage in food/beverage anaerobic plants

Ovivo

Industrial and municipal water equipment

—

Equipment-led competitor

BWT

Water treatment, industrial and point-of-use

—

European equipment and service competitor

Aquatech International

Industrial water reuse, ZLD, BOO models

Private; n/d

Reuse/ZLD specialist with BOO offerings

Pentair / Culligan

Industrial filtration and treatment, rentals

—

Overlap in smaller-scale industrial and rental installations

Local/regional integrators (e.g., BOSAQ, Owatec, ACQUA.ecologie, Spacedrip)

Circular water, modular reuse

Start-up scale

Niche competitors in modular circular water

Competitor Detail

MetricEkopak FY2025

Revenue

EUR 51.1m

Revenue growth

7.3%

EBITDA margin

-8.4%

Company Snapshot

$57.6M

Revenue

265

Employees

1997

Founded

Deinze, Belgium

Headquarters

SWOT Analysis

Strengths

  • Growing recurring base: Recurring Business revenue grew 19% in FY2025 to EUR 14.5m and 53% in 1H2026 to EUR 9.5m, with first positive half-year segment adjusted EBITDA (EUR 1.4m). [FY2025 accounts; 1H2026 note 5]
  • Record backlog: Project Business backlog rose from EUR 36m (end-2024) to EUR 49m (end-2025), roughly 1.3x FY2025 project revenue. [FY2025 PR]
  • Blue-chip clientele: WaaS and projects for TotalEnergies, ArcelorMittal, Agristo, Coca-Cola/Fujifilm/IFF (NWB) with very low historical credit losses. [1H2026 note 6, 12]
  • International reach post-GWE: non-Belgian revenue was 73% of 1H2026 sales; APAC up to 14% of revenue. [1H2026 note 7.1]
  • Committed anchor shareholder: Alychlo funded EUR 14.1m equity (2025), co-funded EUR 5m convertible (Apr-2026) and offers up to EUR 5.64m further (Sep-2026). [1H2026 notes 14, 21]
  • Proven break-even capability at scale: H2-2025 delivered EUR 29.4m revenue with positive adjusted EBITDA (EUR 0.36m) on a stable payroll. [FY2025 PR]
  • Modern, certified production/HQ campus: Deinze campus (BREEAM Outstanding, Sep-2026) provides capacity without further major capex. [MarketScreener; 1H2025 note 10]

Weaknesses

  • Persistent losses: net loss EUR 12.2m (FY2024) and EUR 13.8m (FY2025); adjusted EBITDA negative both years. [FY2025 accounts]
  • Liquidity and going concern: auditor's report expected to include a material-uncertainty paragraph; 1H2026 notes state continuity depends on asset monetisation. [FY2025 PR; 1H2026 note 2.1]
  • High leverage: net financial debt EUR 73.5m excl. leases at June 2026 vs equity EUR 41.1m; bank principal moratorium. [1H2026 balance sheet; PR]
  • Negative tangible equity: goodwill+intangibles EUR 46.1m exceed equity EUR 41.1m (June 2026). [1H2026 balance sheet]
  • Revenue volatility: H1-2024 EUR 32.6m → H1-2025 EUR 21.7m → H2-2025 EUR 29.4m → H1-2026 EUR 23.5m. [interim reports]
  • Governance/disclosure track record: Waterkracht revenue reversed out of FY2024 and FY2025; FSMA investigation still generating legal costs in 2026. [1H2026 note 5]
  • Leadership churn: three CEO regimes (Loose → De Cuyper → Messiaen interim) in 13 months. [1H2026 note 21]

Opportunities

  • Off-balance WaaS financing could unlock EPC margins and cash flow without balance-sheet strain, once first assets are transferred. [FY2025 PR]
  • Asset monetisation: EUR 23.0m net book value of DBFMO installations (June 2026) represents a sellable portfolio. [1H2026 note 11]
  • Waterkracht revival: >EUR 100m project; any restructured consortium would be pure upside since it is excluded from accounts. [water-kracht.be; FY2025 PR]
  • Cluster wastewater WaaS replication of the NWB model in other industrial clusters. [1H2026 note 6]
  • Asian WaaS via WaaS Asia JV (first contract signed) and India entity. [1H2026 note 22–23]
  • Structural demand: European water-reuse market projected by Veolia to grow sixfold 2023–2027. [Test Aankoop]

Threats

  • Dilutive recapitalisation: new capital search at a share price (EUR 2.40) far below the 2025 raise (EUR 5.60) and convertible strike (EUR 4.9061). [market data; 1H2026 note 16]
  • FSMA sanctions or referral: FSMA can impose fines or, where criminal infringement may exist, inform the public prosecutor. [De Aandeelhouder 28-Apr-2025]
  • Bank covenant/refinancing risk: EUR 29.3m short-term borrowings at June 2026. [1H2026 note 16]
  • Trade policy: US tariff uncertainty already cost pipeline projects in 2025; Americas still c. 30% of revenue. [1H2025 note 20]
  • Deferred tax asset reversal: EUR 12.4m DTA recognised on EUR 52.9m losses could be impaired if profitability expectations slip. [1H2026 note 8]
  • Competitive pressure from well-capitalised majors offering similar outsourced water models (Veolia, Xylem/Evoqua, Kurita).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
21-Mar-2025Trends reports repeated incomplete/incorrect communication on Waterkracht; FY2024 revenue revised downCredibility shock (context, just before window)
28-Apr-2025FSMA opens administrative investigation into disclosure complianceRegulatory overhang; possible sanctions or settlement
May-2025EUR 15m capital raise at EUR 5.60, Alychlo EUR 14.1m; Pilovan sells 1.08m shares to AlychloMajority control passes to Alychlo
May-2025Jos De Vuyst appointed Chairman; external CEO search launchedGovernance reset
Jun-2025Geert Bossuyt appointed CFOFinance leadership change
1H2025Three new WaaS projects operational; contract with large US breweryRecurring base growth; US momentum
2025Tielt HQ sold for EUR 3.12mOne-off cash and EBITDA gain
28-Jul-2025US–EU tariff agreement (15%); company says uncertainty cost it several pipeline projectsExplains Americas weakness
01-Sep-20251H2025 results: revenue -33% to EUR 21.7m, net loss EUR 7.2m, net debt EUR 68.4mWeak half; backlog EUR 42m
01-Sep-2025JB De Cuyper CEO; Cockpit model; two BUs; cost programmeRestructuring
Mid-Sep-2025Share drops >14% with trading halt after Kepler Cheuvreux liquidity warningMarket stress
2H2025WaaS installations for TotalEnergies (FR) and ArcelorMittal (BE) operational; Agristo India and Nexus W2V USA progressExecution evidence
01-Jan-2026NWB Tilburg acquisition closed (EUR 2.2m)First wastewater WaaS; EUR 5m badwill
16-Jan-2026India subsidiary incorporatedAPAC expansion
27-Jan-2026Off-balance WaaS partnership with infrastructure fund announcedStrategic financing shift
25-Feb-2026EPICo II withdraws from WaterkrachtFlagship project jeopardised
02-Mar-2026FY2025 results: revenue +7.3% to EUR 51.1m; H2 adj. EBITDA positive; backlog EUR 49m; 2028 targets reiterated; going-concern emphasis expectedMixed; KBC puts Hold/EUR 5.50 under review
02-Mar-2026KBC notes FY2025 adj. EBITDA (-EUR 3.4m) far below its +EUR 8.9m forecastEstimate reset
10-Apr-2026Integrated Annual Report 2025 publishedStatutory
Apr-2026EUR 5.0m subordinated convertible from Alychlo, Chasqui, BosvanLiquidity support
1H2026Additional working-capital lines of EUR 2.35m drawnLiquidity
1H2026WaaS Asia signs first contractAsian WaaS start
12-May-2026AGMStatutory
20-Jul-2026CEO JB De Cuyper resigns after ten monthsLeadership instability
03-Aug-2026Wim Messiaen appointed interim CEO; KBC Hold, target EUR 4.60Stop-gap leadership
c. 25-Aug-2026Six-month Waterkracht deliberation period expires (outcome not publicly disclosed in sources reviewed)Key unknown
01-Sep-20261H2026 results: revenue +9% to EUR 23.5m, adj. EBITDA -EUR 1.2m, EBITDA EUR 3.4m incl. badwillWeak underlying
01-Sep-2026Alychlo loan of up to EUR 5.639m matching bank principal moratorium; capital search with adviser; additional cost cuts; Cockpit abolished; Loose becomes non-executive; related-party transaction noticeFinancial distress signals
01-Sep-2026KBC Securities withdraws rating and target; share -6% to EUR 4.05Coverage loss
08-Sep-2026Company "News Splash – September"Communications
24-Sep-2026Deinze HQ achieves BREEAM OutstandingESG credential
2-Oct-2026Share at EUR 2.82; 52-week low EUR 2.755Continued derating
16-Oct-2026Share closes EUR 2.40 (-54.7% YTD); market cap c. EUR 42mNew lows

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

6 charts
Revenue by Segment: Total revenue rose from EUR 47.6 Mn in FY2024 to EUR 51.1 Mn in FY2025.
Ekopak NV — Revenue by Segment
Series (EUR Mn)FY2024FY2025
Total revenue47.651.1
Project Business35.536.6
Recurring Business12.214.5

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. Ekopak NV, "Publicatie Financiële Resultaten 1e jaarhelft 2026" incl. IFRS Tussentijdse Verkorte Geconsolideerde Financiële Staten, 1 Sep 2026 (vfb.be PDF).
  2. Ekopak NV, "Publicatie Financiële Resultaten 2e jaarhelft en volledig jaar 2025 (incl. update Waterkracht project)", 2 Mar 2026 (vfb.be / ekopakwater.com PDF).
  3. Ekopak NV, "Publication 1st Half of 2025 Financial Results" incl. IFRS Interim Condensed Consolidated Financial Statements, 1 Sep 2025 (live.euronext.com PDF).
  4. Ekopak NV, Geïntegreerd Jaarverslag 2025 (excerpts, vfb.be PDF).
  5. Ekopak NV press release on iSERV, 26 Apr 2021; Waterkracht press release, Sep 2024.
  6. Alychlo, "Giant step for EKOPAK with acquisition of GWE", 14 Sep 2023.
  7. Euronext Brussels issuer/IPO page for EKOPAK.
  8. water-kracht.be FAQ.
  9. De Aandeelhouder / ABM Financial News: 28 Apr 2025; 2 Mar 2026 (two articles); 21 Apr 2026; 1 Sep 2026.
  10. Made in (West-/Oost-Vlaanderen): FSMA article (Apr 2025); Coucke capital increase (May 2025); share-price fall (Sep 2025).
  11. MarketScreener quote page (16 Oct 2026) and news list; Test Aankoop Invest (Feb 2025; Mar 2026; quote page 2 Oct 2026); Beursduivel/IEX; Beursgenoten; TipRanks income statement; Investing.com; Revelio Labs; CB Insights; statbase.

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.